Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
+316K
-
Total reported value, excl. options
-
$140M
-
Value change
-
+$4.08M
-
Number of buys
-
30
-
Number of sells
-
-18
-
Price
-
$12.74
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2016
60 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2016.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
of 55.2M outstanding shares and own 19.85% of the company stock.
Largest 10 shareholders include FMR LLC (3.97M shares), Bain Capital Public Equity Management, LLC (1.51M shares), Partner Fund Management, L.P. (1.38M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (446K shares), BlackRock Fund Advisors (385K shares), Casdin Capital, LLC (385K shares), VANGUARD GROUP INC (382K shares), GOLDMAN SACHS GROUP INC (307K shares), EVENTIDE ASSET MANAGEMENT, LLC (300K shares), and DEERFIELD MANAGEMENT CO (235K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.